Latest Insider Transactions at Data Knights Acquisition Corp. (DKDCW)
This section provides a real-time view of insider transactions for Data Knights Acquisition Corp. (DKDCW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Data Knights Acquisition Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Data Knights Acquisition Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 01
2024
|
Sherry Coonse Mc Craw Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,342
+50.0%
|
-
|
|
Oct 01
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
230,769
+7.71%
|
$0
$0.57 P/Share
|
|
Sep 20
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,600
+0.06%
|
$0
$0.66 P/Share
|
|
Sep 18
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
800
+0.03%
|
$0
$0.68 P/Share
|
|
Aug 30
2024
|
Robert Lawrence Golden Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+40.77%
|
-
|
|
Aug 21
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
100
+0.0%
|
$100
$1.22 P/Share
|
|
Aug 16
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
14
+0.0%
|
$14
$1.41 P/Share
|
|
Aug 15
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
10
+0.0%
|
$10
$1.34 P/Share
|
|
Aug 14
2024
|
Andrew B Zeinfeld Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,260
+6.35%
|
-
|
|
Aug 14
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
13
+0.0%
|
$13
$1.35 P/Share
|
|
Aug 13
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
2,237
+0.09%
|
$2,237
$1.19 P/Share
|
|
Aug 12
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
913
+0.04%
|
$913
$1.1 P/Share
|
|
Jul 08
2024
|
Eric Casaburi Director |
BUY
Open market or private purchase
|
Direct |
4,100
+7.1%
|
$0
$0.92 P/Share
|
|
May 10
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,203
+0.05%
|
$0
$0.52 P/Share
|
|
May 08
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.0%
|
$0
$0.69 P/Share
|
|
May 07
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
106
+0.0%
|
$0
$0.68 P/Share
|
|
May 06
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
214
+0.01%
|
$0
$0.65 P/Share
|
|
May 03
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
350
+0.01%
|
$0
$0.6 P/Share
|
|
May 02
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
100
+0.0%
|
$0
$0.62 P/Share
|
|
Apr 24
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
100
+0.0%
|
$0
$0.65 P/Share
|
|
Mar 22
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
100
+0.0%
|
$0
$0.79 P/Share
|
|
Mar 06
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
16
+0.0%
|
$0
$0.84 P/Share
|
|
Mar 05
2024
|
Eric Casaburi Director |
BUY
Open market or private purchase
|
Direct |
2,000
+3.88%
|
$0
$0.74 P/Share
|
|
Feb 29
2024
|
Eric Casaburi Director |
BUY
Open market or private purchase
|
Direct |
575
+1.19%
|
$0
$0.72 P/Share
|
|
Feb 16
2024
|
Eric Casaburi Director |
BUY
Open market or private purchase
|
Direct |
2,000
+4.08%
|
$0
$0.77 P/Share
|
|
Feb 16
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
100
+0.0%
|
$0
$0.82 P/Share
|
|
Feb 08
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
2
+0.0%
|
$2
$1.19 P/Share
|
|
Feb 01
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,357
+0.05%
|
$1,357
$1.45 P/Share
|
|
Jan 30
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
400
+0.02%
|
$400
$1.14 P/Share
|
|
Jan 29
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
950
+0.04%
|
$950
$1.04 P/Share
|
|
Jan 26
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
5,386
+0.21%
|
$0
$0.56 P/Share
|
|
Jan 25
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
2,304
+0.09%
|
$0
$0.55 P/Share
|
|
Jan 24
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
740
+0.03%
|
$0
$0.55 P/Share
|
|
Jan 23
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
720
+0.03%
|
$0
$0.52 P/Share
|
|
Jan 22
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
5,035
+0.2%
|
$0
$0.49 P/Share
|
|
Jan 19
2024
|
Eric Casaburi Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+50.0%
|
-
|
|
Jan 19
2024
|
Thomas Kosasa Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+0.53%
|
-
|
|
Jan 19
2024
|
Aaron Green Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+6.52%
|
-
|
|
Jan 19
2024
|
Robert Lawrence Golden Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+49.83%
|
-
|
|
Jan 19
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+1.76%
|
-
|
|
Jan 19
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
60
+0.0%
|
$0
$0.48 P/Share
|
|
Jan 17
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
362
+0.01%
|
$0
$0.61 P/Share
|
|
Jan 16
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$0
$0.75 P/Share
|
|
Jan 12
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
20
+0.0%
|
$0
$0.81 P/Share
|
|
Jan 10
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
20
+0.0%
|
$0
$0.85 P/Share
|
|
Jan 09
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
100
+0.0%
|
$0
$0.86 P/Share
|
|
Jan 08
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
10
+0.0%
|
$0
$0.83 P/Share
|
|
Jan 04
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
180
+0.01%
|
$0
$0.84 P/Share
|
|
Jan 02
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
20
+0.0%
|
$0
$0.82 P/Share
|
|
Dec 27
2023
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
10
+0.0%
|
$10
$1.03 P/Share
|